Gutierrez CLD, Quero-Taggaoa AKH, Uy TCF, Veloso JAD. High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. J Med Cases. 2026;17(4):146-152. doi:10.14740/jmc5237